Genevac has produced a new 20-page technical booklet introducing its HT Series II and Mega Series II centrifugal evaporators, available as downloadable PDF or in hard copy on request
Genevac says the HT-Series II range sets the benchmark for flexible, high performance evaporation designed with the specific needs of life science research in mind.
From the compact HT-4X to the latest HT-24 system each HT evaporator carries the hallmark of Genevac's 15 years experience in solvent removal with leading edge features that provide superior sample protection, flexibility for multiple applications, consistency of results, robust build quality, ease-of-use, rapid high-throughput results and low maintenance.
For ultra-high throughput applications using sample formats with a footprint larger than a microplate the Mega Series II uniquely combines the required large sample capacity with ultimate evaporator performance and operational flexibility.
The booklet provides a detailed introduction for all current products ranging from the compact HT-4X series optimised for drug discovery to the HT-8, HT-12, HT-24 and Mega series, providing the ultimate in high throughput evaporator technology.
A selection guide helps you to select the most appropriate system for your application.
Further information is provided on Genevac's wide range of sample holders, intuitive yet powerful software and options for specialist applications including highly volatile, explosive or acidic samples.
Founded in 1990, Genevac today employs around 85 people, with manufacturing, R+D and marketing headquartered in Ipswich, UK.
A US subsidiary based in Valley Cottage, NY, together with a network of sales and service representatives provides informed local sales, service and technical support to customers in North America.
Genevac today offers a comprehensive portfolio of evaporators to suit almost any solvent removal application, purchasing budget or productivity requirement.
